看多
BTG - I see potential
Global Blood Therapeutics’ candidate (Voxelotor) has a lot of potential for SCD.
There are a lot of articles on Sickle Cell Disease (SCD) which I strongly invite you to read.
From a Technical Analysis point of view, I like what I see in GBT's chart.
For me, the stock ended an a-b-c correction and is now preparing to move forward.
Confirmation is needed but overall the chart looks robust.
There are a lot of articles on Sickle Cell Disease (SCD) which I strongly invite you to read.
From a Technical Analysis point of view, I like what I see in GBT's chart.
For me, the stock ended an a-b-c correction and is now preparing to move forward.
Confirmation is needed but overall the chart looks robust.
Winstox
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。